Correction to: Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study
BMC Cancer
.
2021 Dec 2;21(1):1291.
doi: 10.1186/s12885-021-09015-9.
Authors
Shebli Atrash
1
,
Philippe Thompson-Leduc
2
,
Ming-Hui Tai
3
,
Shuchita Kaila
3
,
Kathleen Gray
3
,
Isabelle Ghelerter
4
,
Marie-Hélène Lafeuille
4
,
Patrick Lefebvre
4
,
Adriana Rossi
5
Affiliations
1
Levine Cancer Institute, Charlotte, NC, USA.
2
Analysis Group, Inc, 1190 avenue des Canadiens-de-Montréal, Deloitte Tower, Suite 1500, Montreal, QC, H3B 0G7, Canada. Philippe.Thompson-Leduc@analysisgroup.com.
3
Janssen Scientific Affairs, LLC, Horsham, PA, USA.
4
Analysis Group, Inc, 1190 avenue des Canadiens-de-Montréal, Deloitte Tower, Suite 1500, Montreal, QC, H3B 0G7, Canada.
5
Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
PMID:
34856934
PMCID:
PMC8638479
DOI:
10.1186/s12885-021-09015-9
No abstract available
Publication types
Published Erratum